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Congenital stationary night blindness (CSNB) is a heterogeneous group of non-progressive inherited retinal disorders with characteristic
electroretinogram (ERG) abnormalities. Riggs and Schubert-Bornschein are subtypes of CSNB and demonstrate distinct ERG features.
Riggs CSNB demonstrates selective rod photoreceptor dysfunction and occurs due to mutations in genes encoding proteins involved
in rod phototransduction cascade; night blindness is the only symptom and eye examination is otherwise normal. Schubert-Bornschein
CSNB is a consequence of impaired signal transmission between the photoreceptors and bipolar cells. Schubert-Bornschein CSNB is sub-
divided into complete CSNB with an ON bipolar signaling defect and incomplete CSNB with both ON and OFF pathway involvement.
Both subtypes are associated with variable degrees of night blindness or photophobia, reduced visual acuity, high myopia, and
nystagmus.Whole-exome sequencing of a family screened negative for mutations in genes associated with CSNB identified biallelic mu-
tations in the guanine nucleotide-binding protein subunit beta-3 gene (GNB3). Two siblings were compound heterozygous for a deletion
(c.170_172delAGA [p.Lys57del]) and a nonsense mutation (c.1017G>A [p.Trp339*]). The maternal aunt was homozygous for the
nonsense mutation (c.1017G>A [p.Trp339*]). Mutational analysis of GNB3 in a cohort of 58 subjects with CSNB identified a sporadic
case individual with a homozygous GNB3 mutation (c.200C>T [p.Ser67Phe]). GNB3 encodes the b subunit of G protein heterotrimer
(Gabg) and is known to modulate ON bipolar cell signaling and cone transducin function in mice. Affected human subjects showed
an unusual CSNB phenotype with variable degrees of ON bipolar dysfunction and reduced cone sensitivity. This unique retinal disorder
with dual anomaly in visual processing expands our knowledge about retinal signaling.Congenital stationary night blindness (CSNB) is a het-
erogeneous group of non-progressive inherited retinal
disorders that follow autosomal-dominant, autosomal-
recessive, or X-linked patterns of inheritance.1 CSNB
results from defects in visual signal transduction either
within rod photoreceptors or in rod and cone bipolar path-
ways.1 Full-field electroretinogram (ERG) testing is an essen-
tial tool to diagnose CSNB and helps to localize the func-
tional deficit to photoreceptor or bipolar-cell signaling.1,2
Inbrief, abrightflash (3.0 and10.0 cd.s.m2 [candela second
per square meter] as defined by the International Society
for Clinical Electrophysiology of Vision [ISCEV]) under
dark-adapted (DA) conditions normally elicits an initial
negative wave (a-wave) that reflects phototransduction-
related photoreceptor hyperpolarization predominated by
the rods; the subsequent positive wave (b-wave) mostly re-
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initial a-wave generated by cone photoreceptor hyperpolar-
izationwithanadditional contribution fromconeOFFbipo-
larcells; the subsequentb-wave is generated fromwithinON
and OFF bipolar cells. The LA 30 Hz stimuli (3.0 cd.s.m2)
lead to a sinusoidal response generated in the inner retina
that is driven by cones.3–7
The most frequent forms of CSNB have a normal fundus
and can be subdivided into Riggs (CSNBAD1 [MIM:
610445], CSNBAD2 [MIM: 163500], CSNBAD3 [MIM:
610444], CSNB1D [MIM: 613830], and CSNB1G
[MIM: 616389]) and Schubert-Bornschein (CSNB1A [MIM:
310500], CSNB1B [MIM: 257270], CSNB1C [MIM:
613216], CSNB1E [MIM: 614565], CSNB1F [MIM: 615058],
CSNB2A [MIM: 300071], and CRSD [MIM: 610427]) types
on the basis of distinct ERG abnormalities.8,9 Riggs CSNB
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consistent with primary rod dysfunction; cone function is
preserved. Night blindness might be the only symptom
andaffected individuals usually havenormal distancevisual
acuity. Riggs CSNB is linked to mutations in proteins
involved in rod phototransduction and can be inherited
as autosomal-dominant (RHO [MIM: 180380], PDE6B
[MIM: 180072], and GNAT1 [MIM: 139330]) and recessive
(GNAT1 and SLC24A1 [MIM: 603617]) traits.10–15 Schu-
bert-Bornschein CSNB is characterized by normal DA
a-wave and reduced b-wave (electronegative configuration:
b/a < 1) in response to a bright flash (3.0 or 10.0 cd.s.m2),
consistent with impaired signal transmission between the
photoreceptors and bipolar cells. Subjects with Schubert-
Bornschein CSNB commonly present with some degree of
night blindness, variable photophobia, nystagmus, reduced
visual acuity, and myopia.1 Schubert-Bornschein CSNB
is subcategorized into complete (c) and incomplete (ic)
CSNB.16 cCSNB is characterized by selective ON bipolar
cell dysfunction, and icCSNB is due to a signaling defect
involving both ON and OFF bipolar pathways. cCSNB is
linked to mutations in NYX (MIM: 300278), GRM6 (MIM:
604096), TRPM1 (MIM: 603576), GPR179 (MIM: 614515),
and LRIT3 (MIM: 615004); these genes encode proteins
localized at the dendritic tip ofONbipolar cells.17–25 icCSNB
is linked to mutations in CACNA1F (MIM: 300110), CABP4
(MIM: 608965), and CACNA2D4 (MIM: 608171), coding
for proteins localized to the photoreceptor synaptic termi-
nal.26–29 Mutations in known genes do not account for all
cases of CSNB, and more gene defects are yet to be discov-
ered.1 Identification of new gene defects will enable better
understanding of visual signal processingwithin the photo-
receptors and from photoreceptors to bipolar cells.
The study protocol followed the tenets of theDeclaration
of Helsinki and was approved by the institutional ethics re-
viewboardof eachparticipatinghospital or university. Prior
informedconsentwasobtained fromall participatingmem-
bers and parents (on behalf of children). Family A, with
three affected individuals, was identified at the Hospital
for Sick Children, Toronto (Figure 1A). Affected members
had mildly reduced vision and normal fundus appearance;
childhood-onset night blindness was present in the pro-
band (III-2) and maternal aunt (II-5). Mutational analysis
of the proband did not identify any pathogenic variant in
17 genes known to bemutated inCSNBor in 114 additional
genes known to bemutated in retinal dystrophies. 11mem-
bers of the familywere recruited.Detailed eye examinations
and ISCEV standard ERG testing was performed in ten
members (except I-1).2,30 LA ERGwith long-duration white
flashes (150 ms and 200 ms; 250 cd.m2; to analyze cone
ON andOFF pathways) was performed in the three affected
members.31 Whole-exome capture and sequencing (WES)
was performed in two trios (two affected subjects and their
unaffected parents; Figure 1A) at The Center for Applied
Genomics, Toronto as previously described (see the Supple-
mental Material and Methods).32 The filtering steps used
in the WES analysis in the pedigree are summarized in
Table S1. Under the assumption of autosomal-recessive1012 The American Journal of Human Genetics 98, 1011–1019, Mayinheritance, genes carrying Rtwo rare non-synonymous
codingvariants, splicing variants, or indelswere prioritized;
only 13 genes were shared among III-2 and II-5. WES data
from the unaffected parents and sibling were sequen-
tially used to filter through shared rare variants. A single
variant in guanine nucleotide-binding protein subunit
beta-3 (GNB3 [GenBank: NM_002075.3] or Gb3 [MIM:
139130]) was shared between III-2 and II-5. This variant,
c.1017G>A in exon 10 and predicted to lead to nonsense
mutation p.Trp339*, was homozygous in II-5 and heterozy-
gous in III-2. Individual III-2 also carried a second heterozy-
gous variant in GNB3; this variant, c.170_172delAGA
in exon 4, was predicted to cause an in-frame deletion,
p.Lys57del. Both the c.170_172delAGA and c.1017G>A
variants were confirmed by Sanger sequencing (conditions
available on request) and segregated with disease pheno-
type in the family (Figure 1A). Neither variant was reported
in any public databases, including the Exome Aggregation
Consortium (ExAC) Browser, theNHLBI ESP ExomeVariant
Server, and the 1000 Genomes Browser (release 14).33
GNB3 mutational analysis was performed with Sanger
sequencing (conditions available on request) in 58 addi-
tional CSNB cases; most individuals were excluded for
mutations in genes associated with CSNB. The samples
originated from different centers in Europe, the United
States, Canada, and Israel. A presumably homozygous
missense variant, c.200C>T in exon 4 ofGNB3 and leading
to p.Ser67Phe, was identified in a sporadic case sub-
ject (IV-3, family B; Figure 1B) clinically investigated at
the Centre National de Re´fe´rences Maladies Sensorielles
Ge´ne´tiques in Montpellier (this individual was excluded
for mutations in all known genes associated with CSNB).
This extremely rare variant was found at a low frequency
in the ExAC (MAF ¼ 0.00004) and ESP (MAF ¼ 0.0002)
databases, but never in a homozygous state. In view of
consanguineous ancestry, we determined this mutation
to be most likely homozygous in the subject. Co-segrega-
tion could not be performed because the parents were
deceased and no other family members were available for
testing. Hence, the possibility of a heterozygous deletion
involving the entirety of GNB3 cannot be completely
excluded.
Geneious v.8.1.8 was used to align the amino acid
sequences of GNB3 and GNB proteins in available spe-
cies.34 The amino acid residues p.Lys57 and p.Trp339 in
GNB3 are highly conserved across vertebrates, including
zebrafish; p.Ser67Phe is conserved in most verte-
brates (except frogs; Figure 1C). Residues p.Lys57 and
p.Trp339 are conserved in all human GNB paralogs and
in GNB proteins across a wide range of taxonomic groups
(fungi, plants, and single-celled eukaryotes; Figures 1C
and 1D). The p.Ser67 residue is conserved in all human
paralogs, except GNB5, and is moderately conserved
in GNB proteins present in other taxonomic groups.
The mutant p.Phe67 is not seen in any paralog or
homolog. All three variants, p.Lys57del, p.Trp339*, and
p.Ser67Phe, were predicted by MutationTaster to be5, 2016
Figure 1. Genetic Pedigree of Both Families and Protein Conservation Maps and Protein Modeling Results for the Detected GNB3
Variants
(A) A three generation pedigree (family A) with three affected members.
(B) Pedigree of a sporadic case subject (family B) born to distantly consanguineous parents.
(C) Conservation map of GNB3 in vertebrates and in GNB homologs across a range of taxonomic groups; Lys57 and Trp339 were the
most conserved amino-acid residues.
(D) Conservation of amino-acid residues across GNB paralogs.
(E and F) Homologymodels of GNB3 generatedwith Phyre2. The structure of the GNB3 homologymodel based on the 1TBG structure of
GNB1 (chain A [PDB: 1TBG]) and mutated residues are labeled.
(G andH) Surface representation of GNB3 illustrates how termination of the protein at Trp339 would create a significant loss of structure
and the exposure of normally buried residues. The Trp surface (green) is shown in (G), and the loss of structure with removal of Trp339
and Asn340 (highlighted by yellow asterisk) is shown in (H).
(I) Illustration of the location of Ser67 showing the two potential hydrogen bonds to Ala322 and Asp323; the p.Ser67Phe mutation
would disrupt both of these interactions. Trp339 is located in the same region of the b-barrel structure, potentially indicating an impor-
tant biological role for this region of GNB3.
(J and K) The loss of Lys57 (p.Lys57del) would cause disruption of Gb5:RGS interactions. GNB3 is shown in blue, RGS in green, Lys57 as
red sticks, and the binding aspartate as orange sticks.disease causing with probabilities >0.99. Residues
p.Lys57, p.Trp339, and p.Ser67 had PhylopPvert-100
average scores of 7.3, 9.6, and 4.1, respectively (strong
conservation). The PhyloPMam average conservation
score was 2.83 for p.Trp339 (strong conservation);
p.Lys57 and p.Ser67 had scores of 2.22 and 2.46, respec-
tively (moderate conservation).The AmericGNB3 located on chromosome 12p13.31 encodes the
b subunit of the G protein heterotrimer (Gabg); it is ex-
pressed in the retina and has been previously associated
with a partial form of cCSNB in mice (Gnb3/).35,36
GNB3 is a WD40 protein made up of seven highly
conserved repeating units (~40 amino acid motifs) usually
ending with Trp-Asp (WD).37 WD40 repeat motifs act asan Journal of Human Genetics 98, 1011–1019, May 5, 2016 1013
sites for protein-protein interaction, and WD40 pro-
teins regulate cellular function, including transmembrane
signaling.38 Residues Lys57 and Ser67 involve WD40
repeat 1, and Trp339 involves WD40 repeat 7. To deter-
mine the pathological basis of the identified mutations,
we created a homology model of GNB3 from the known
GNB1 (Gb1) amino-acid sequence (shares 83% identity
and 97% amino acid similarity with GNB3) structure by us-
ing Phyre2 software with a confidence score of 100 (Figures
1E and 1F).39,40 The Gb1 subunit forms a seven-bladed
b propeller, typical ofWD40 repeat proteins, and the entire
sequence of GNB3was fit onto this structure. Despite being
at the extreme C terminus of the GNB3 protein chain,
Trp339 occupies an important position in the b-propeller
structure, buried between the first and last b sheets that
constitute the propeller. If a stop codon is introduced in
place of Trp339, both Trp339 and Asn340 would be
removed, creating a significant distortion of the circular
propeller structure and exposing normally buried residues
(Figures 1G and 1H). The b-propeller fold is commonly
used to facilitate protein-protein interactions and the iden-
tified p.Trp339* would pathologically affect the ability of
GNB3 to form important interactions within the G protein
signaling complex. The residue Ser67 lies at the top ridge
of the overall b-barrel structure of GNB3 with two po-
tential hydrogen-bonding partners Ala322 and Asp323
(Figure 1I). The p.Ser67Phe mutation would remove the
ability to participate in both hydrogen bonds, disrupting
the structure of the top of the barrel where other protein-
protein interactions occur. Interestingly, the region of the
b barrel disrupted by p.Ser67Phe is the same region disrup-
ted by p.Trp339*, potentially indicating that this ridge or
geographic region of GNB3 forms interactions important
for cellular function. The other variant, p.Lys57del, lies
within a surface loop on the GNB3 structure. To determine
how this mutation might affect Gb protein interactions
with regulators of G protein signaling (RGS), we used
the X-ray crystal structure of a Gb5:RGS complex (PDB:
2PBI).41 Lys57 forms a conserved interaction with an
aspartate in the RGS protein (Figures 1J and 1K), and loss
of the Lys57 residue would cause disruption of bonding be-
tween GNB3 and cognate Gb binding partners, inhibiting
the formation of effective G protein complexes.
The ocular phenotype of the four affected individuals is
summarized in Table S2. Childhood-onset night blindness
was observed in three subjects. Photophobia and color
vision deficits were noted only in middle aged subjects
(II-5, family A and IV-3, family B). None had nystagmus
and all subjects had a best-corrected visual acuity of
20/30 or better. Mild myopia was observed in one; two
had hyperopia. All had normal fundus and visual fields.
Central retinal thickness and retinal lamination were
normal (spectral domain-optical coherence tomography)
in all subjects; Gnb3-null mice also showed normal retinal
morphology.35,42 The visual parameters remained stable
on follow-up in all cases; the proband from family B had
47 years of follow-up. These findings are consistent with1014 The American Journal of Human Genetics 98, 1011–1019, Maythe diagnosis of CSNB.43 All seven unaffected members
in family A had normal eye examinations and normal
ERGs (similar to the control eye data provided in
Figure 2E).
The ERG phenotype in all affected subjects is shown
in Figure 2 and the Supplemental Data (including Table
S3). Rod ERG findings suggested partial (sibling pair,
p.Lys57del and p.Trp339*; Figures 2A and 2B) or severe
rod ON bipolar dysfunction (II-5, family A, p.Trp339* ho-
mozygous and IV-3, family B, p.Ser67Phe homozygous;
Figures 2C and 2D). The single flash and 30 Hz LA ERGs
were normal in the sibling pair. The single flash LA 3.0
ERG a-wave showed normal amplitudes, but implicit
times were markedly delayed in two subjects (24 ms in
II-5, family A and 31 ms in IV-3, family B [normal range:
14–17 ms]; Figures 2C and 2D). The subsequent b-wave
showed reduced amplitudes and delayed implicit times
(36 ms in II-5, family A and 49 ms in IV-3, family B
[normal range 27–30 ms]). The LA 30 Hz flicker ERG
implicit times were also delayed in these two individ-
uals. The LA ERG findings in these two subjects are pecu-
liar and reminiscent of the functional abnormalities
seen in Gnb3-null mice; this observation is suggestive
of reduced cone photoreceptor sensitivity, atypical of
CSNB.42 Further testing in individual II-5 (family A)
confirmed this reduced cone sensitivity ([log(Sc)] ¼ 0.83
[normal range: 1.59–2.17]); however, cone photoreceptor
maximal amplitude (Rmp3 ¼ 97mV) was normal in this
individual (Supplemental Data). The normal or border-
line LA 30 Hz flicker amplitudes in the two subjects
(II-5, family A and IV-3, family B) suggest relative preser-
vation of cone OFF-pathway. Long duration stimulus
testing on family A confirmed cone OFF-pathway preser-
vation (normal d-wave; Figures 2A–2C); two subjects
showed selective cone ON bipolar dysfunction (reduced
b-wave; Figures 2A and 2C).
The GNB3 sequence is extremely conserved across spe-
cies and has a homology of 100%, 98%, and 92% with
macaques, mice, and zebrafish respectively.44 In the
mammalian retina, GNB3 immuno-localizes to the ON
bipolar cells and cone photoreceptors in multiple species,
including mice, macaques, and dogs.35,44–46 The Gnb3-
null mice show partial preservation of ON bipolar
pathway signaling as seen in the sibling pair (III-1 and
III-2, family A).35 In addition to the ON bipolar defect,
the Gnb3-null mice show reduced cone sensitivity as
seen in two subjects in the study (II-5, family A,
p.Trp339* homozygous and IV-3, family B, p.Ser67Phe
homozygous).42 The coexistence of cone sensitivity deficit
and ON bipolar signaling deficit defines a unique retinal
disorder with cone-receptoral and rod and cone post-
receptoral phenotypes.
G proteins are heterotrimeric proteins consisting of sin-
gle a, b, and g subunits. There are at least 20 different Ga,
6 different Gb, and 13 different Gg subunits that associate
together to form specific heterotrimer combinations and
perform unique functions.35,37,42,47 In the mammalian5, 2016
Figure 2. ERG Traces from the Right Eye of All Four Affected Individuals and a Control Subject
ERG traces from family A (A, III-2; B, III-1; C, II-5), the family B proband (D; it is noted that only standard ERG protocols were tested in
the subject), and a control subject (E). The nomenclature of the responses relates to the adaptive state of the eye (DA, dark adapted; LA,
light adapted) and stimulus intensity in cd.s.m2 (DA 0.01 relates to dark adapted responses to 0.01 cd.s.m2 flash). The DA b-wave was
either reduced or non-detectable between stimulus intensities of 0.0025 and 0.1 cd.s.m2. On bright flash stimulation in the dark (3.0
and 10.0 cd.s.m2), the a-wave is of normal amplitude; b-wave is markedly reduced at both intensities. The DA ERG results (DA 0.0025 to
DA 10.0) are consistent with rod ON bipolar dysfunction in all affected subjects (A–D). The LA 3.0 single flash ERG showed normal
a-wave amplitudes in all subjects, but the slope of the a-wave was reduced, and implicit times were markedly delayed in two subjects
(C and D); the same subjects showed reduced b-wave. The 30 Hz flicker responses were completely normal in two subjects (represented
in A and B), and showed marked delay in two subjects (represented in C and D). These findings suggest reduced cone sensitivity in two
subjects (C and D). Long duration stimulation (ON-OFF ERG) showed selective reduction of b-wave in two subjects (A and C), consistent
with cone ON bipolar dysfunction; d-wave (OFF response) was normal in all three tested (A–C).photoreceptors, light-activated opsins stimulate G-protein
transducins. Rods have Gat1b1g1 as their G protein
transducin, whereas cones have Gat2b3gt2 as their G pro-
tein transducin.45–49 The G protein transducin activates
phosphodiesterase, leading to a reduction in the levels
of cGMP, closure of cGMP-gated channels, and membrane
hyperpolarization. Hyperpolarization of the photore-
ceptors leads to decreased release of glutamate into
the synapse, which deactivates the metabotropic gluta-
mate receptor 6 (GRM6) on the ON bipolar cells (rods
and cones). This activates the heterotrimeric G protein
Gaob3g13 to release the Gao subunit to open the non-
selective channel TRPM1, leading to ON bipolar cell depo-
larization.50–58 Hence, the Gb3 subunit is specifically
involved in modulating cone transducin function as
well as cone and rod ON bipolar cell signaling. Conse-
quently, severe biallelic mutations in GNB3 likely causeThe Americdysfunction of the G protein in cones (Gat2b3gt2) and
in rod and cone ON bipolar cells (Gaob3g13); this causes
the unique dual phenotype of CSNB with reduced cone
sensitivity. The in-frame deletion (p.Lys57del) might
confer some residual binding capability of the Gb3 to
the g13 and gt2 subunits in the ON bipolar cells and
cones, respectively; this might account for the residual
ON bipolar signaling and relatively preserved cone func-
tion in the compound heterozygote individuals (sibling
pair in family A, p.Lys57del and p.Trp339*). The partial
preservation of cone ON bipolar signaling could explain
the absence of a broadened trough of LA 3.0 single flash
and flicker ERGs in the sibling pair.
In any G protein heterotrimer, Gb and Gg subunits
functionally form a monomer that cannot be dissociated
under normal conditions. Truncating mutations at any
point in Gb3 would prevent correct assembly of the Gbgan Journal of Human Genetics 98, 1011–1019, May 5, 2016 1015
functional monomer, thereby compromising G protein
function, which would be the case for null alleles in
GNB3 (p.Trp339* homozygous).37,59 The ON bipolar cells
in Gnb3-null mice showed reduced immuno-localization
of other G protein subunits (Gao and Gg13), glutamate
receptor (GRM6), and ion channel (TRPM1).35 Mutations
in TRPM1 and GRM6 cause ON bipolar signaling dysfunc-
tion (cCSNB) in humans; animal models of Trpm1,
Grm6, Gao, and Gb3 also cause an ON bipolar signaling
defect.19–22,35,53,60–64 The human GNB3-mutant pheno-
type showed consistent ON bipolar involvement, but
the severity was variable, which seems to correlate with
the type of mutations. The cone photoreceptors in
Gnb3-null mice showed reduced expression of other G
protein subunits (Gat2 and Ggt2), but members of photo-
transduction cascade (opsins, CNGA3, CNGB3, and
RGS9BP) were normally expressed and localized. Hence,
the Gnb3-null mice showed reduced cone sensitivity,
but saturated cone response was normal.42 The human
phenotype variably demonstrated cone sensitivity deficit;
the maximal cone photoreceptor response was normal.
Unlike in mammals, Gnb3 is expressed in both rods and
cones in chicken retinas; a progressive retinal degenera-
tion has been reported in aged Gnb3-null chicken.35,44,65
Of note, a prior study that investigated a wide range of
generalized photoreceptor dystrophies and macular dys-
trophy (including MIM: 248200) identified no mutations
in GNB3.66
A single nucleotide polymorphism in GNB3 (c.825C>T,
rs5443, allele frequency: 35.98%) has been associated
with an increased risk of multifactorial disease, such as
hypertension (MIM: 145500], depression (MIM: 608516),
obesity (MIM: 601665), and Alzheimer disease (MIM:
104300).67–71 An unbalanced translocation between chro-
mosomes 8 and 12, der(8)t(8;12) (p23.1;p13.31), has been
associated with childhood obesity syndrome; GNB3 is one
of the 107 genes involved, and transgenic mouse models
carrying duplicate copies of GNB3 were obese.72 A gain
of function of GNB3 is the proposed mechanism confer-
ring risk in these disorders.67,72 The retinal phenotype
discussed in the present study is autosomal recessive in
inheritance and functional loss of GNB3 is the disease
mechanism; all heterozygous carriers in family A were un-
affected. None of the six individuals who underwent WES
(family A) or the proband in family B had the c.825C>T
variant in GNB3. None of the ten members in Family A
or the proband in Family B had hypertension, depression,
obesity, or Alzheimer disease.
To summarize, we identify an unusual and unique
stationary retinal disorder with dual anomaly in visual
processing associated with biallelic mutations in GNB3.
The anomalies include partial or severe defects in ON bi-
polar signaling and variably reduced cone sensitivity.
This GNB3-mutant phenotype commonly presents with
childhood-onset night blindness and middle-age-onset
photophobia, but affected individuals have near normal
vision, absent nystagmus, and no high myopia. The rod1016 The American Journal of Human Genetics 98, 1011–1019, Maysystem always shows evidence of an ON signaling defect;
this can range from severe (as in cCSNB) to mild deficits.
The cone ON bipolar signaling deficit is variable (severe,
mild, or none); specialized ERG techniques (long-duration
stimulus) are needed to uncover this deficit. Cone photo-
receptor sensitivity is reduced in a subset of cases. Some
features of the disease are reminiscent of cCSNB; these
include night-blindness, the non-progressive nature of
the disease, and selective involvement of the ON bipolar
signaling pathway. G proteins are cardinal second mes-
sengers in signal transduction; GNB3 is the third G pro-
tein subunit to be associated with a Mendelian eye dis-
ease, after GNAT1 (Gat1, rod a transducin; CSNB) and
GNAT2 (Gat2, cone a transducin; achromatopsia). This
report enhances our knowledge about visual signal
transduction.Supplemental Data
Supplemental Data include Supplemental Material and Methods
and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.ajhg.2016.03.021.Consortia
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